首页 › 股票 › DYN

DYN — DYNE THERAPEUTICS INC

申报持仓市值$5.09B
持有基金数(最新)468
板块医疗保健

什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么

持有机构数 (Q2 2026)256
机构持仓市值$4.19B · 192.73M 股
新建/增持/减仓/清仓50 / 89 / 73 / 34 · 更新于 2026-11-14
前五大/前十大集中度39.0% / 52.6%
机构整体持仓变动 增持 +2.1% (+3.56M 股)
机构持仓市值变动 上升 +23.9%

最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR

截至Q2 2026,共 256 家机构在其最新 13F 申报中持有 DYN(DYNE THERAPEUTICS INC),合计申报市值 $4.19B,对应 192.73M 股。按股数计算较上季度增持 2.1%(+3.56M 股),申报市值环比上升 23.9%。持仓集中度较高:前五大持有人占申报市值的 39.0%,前十大的集中度为 52.6%。

与上一季度相比,50 家新建仓位、89 家加仓、73 家减仓、34 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。

DYNE THERAPEUTICS INC(DYN)的主要机构持有人包括 T. Rowe Price Investment Management, Inc.、Jupiter Topco LLC、Janus Henderson Group,按 13F 申报市值在本页 468 家持有人中排名居前。

DYN 属于Health Care板块。

本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。

机构逐季持仓趋势

季度 持有机构数 股数 金额 环比净变动
Q3 2026 178 81.58M $1.32B +3.5%
Q2 2026 256 192.73M $4.19B +2.1%
Q1 2026 239 191.38M $3.42B +8.2%
Q4 2025 239 180.76M $3.49B +15.8%
Q3 2025 212 153.85M $1.93B +22.7%
Q2 2025 199 130.29M $1.22B +5.3%
Q1 2025 205 120.74M $1.26B +15.3%
Q4 2024 200 110.90M $2.56B -2.9%

表内 8 个季度中,机构持股合计减少 26%(Q4 2024 → Q3 2026);单季变动最大的是 Q3 2025(+22.7%)。

前 25 大机构持仓人(Q3 2026) — 25 家基金

基金股数金额组合权重变化
BlackRock Inc 14.47M $233.14M 0.01% 增持
Fidelity Management & Research (FMR) 11.15M $179.57M 0.01% 减持
STATE STREET CORP 8.16M $131.43M 0.00% 增持
VANGUARD CAPITAL MANAGEMENT LLC 7.55M $121.67M 0.00% 增持
VANGUARD PORTFOLIO MANAGEMENT LLC 4.69M $75.58M 0.00% 增持
Geode Capital Management 4.40M $70.84M 0.00% 增持
Atlas Venture Life Science Advisors, LLC 历史持仓 3.44M $55.43M 8.78% 减持
JPMorgan Chase & Co 2.91M $47.38M 0.01% 减持
Siren, L.L.C. 历史持仓 2.43M $39.13M 0.93% 增持
Franklin Resources 1.98M $36.72M 0.01% 减持
DIMENSIONAL FUND ADVISORS LP 1.98M $31.96M 0.01% 增持
Fiera Capital Corp 1.44M $23.13M 0.09% 增持
Aberdeen Group plc 1.35M $21.81M 0.03% 减持
VANGUARD FIDUCIARY TRUST CO 1.24M $19.91M 0.00% 增持
Morgan Stanley 1.17M $18.86M 0.00% 增持
BNY Mellon 776.30K $12.51M 0.00% 增持
Marshall Wace 686.68K $11.06M 0.02% 减持
TD ASSET MANAGEMENT INC 612.38K $9.93M 0.01% 增持
RAYMOND JAMES FINANCIAL INC 544.19K $8.77M 0.00% 减持
Vivo Capital, LLC 历史持仓 514.40K $8.29M 0.94% 减持
UBS Group AG 503.48K $8.11M 0.00% 增持
Clearbridge Investments, LLC 414.04K $6.67M 0.01% 持有
Nuveen, LLC 408.74K $6.58M 0.00% 增持
Nantahala Capital Management, LLC 382.44K $6.16M 0.28% 新进
Jump Financial, LLC 338.77K $5.46M 0.05% 新进

↑ 返回持仓列表顶部

更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人

Q2 2026 — 25 家基金

基金股数金额组合权重变化
T. Rowe Price Investment Management, Inc. 30.91M $686.56M 0.45% 持有
BlackRock Inc 12.40M $275.50M 0.01% 增持
Jupiter Topco LLC 12.00M $266.63M 0.11% 新进
Fidelity Management & Research (FMR) 11.21M $248.91M 0.01% 增持
Orbis Allan Gray Ltd 7.01M $155.62M 0.54% 增持
Atlas Venture Life Science Advisors, LLC 历史持仓 6.80M $151.03M 17.14% 减持
VANGUARD CAPITAL MANAGEMENT LLC 6.31M $140.17M 0.00% 减持
TCG Crossover Management, LLC 历史持仓 4.62M $102.50M 2.46% 持有
VANGUARD PORTFOLIO MANAGEMENT LLC 4.05M $89.92M 0.00% 减持
PRICE T ROWE ASSOCIATES INC /MD/ 3.94M $87.44M 0.01% 增持
FCPM III SERVICES B.V. 历史持仓 3.85M $85.47M 11.39% 减持
GEODE CAPITAL MANAGEMENT, LLC 3.74M $83.16M 0.00% 新进
Geode Capital Management 3.74M $83.16M 0.00% 增持
Vestal Point Capital, LP 历史持仓 3.38M $74.96M 1.75% 减持
ORBIMED ADVISORS LLC 历史持仓 3.24M $71.86M 1.45% 增持
Frazier Life Sciences Management, L.P. 历史持仓 3.15M $70.03M 1.52% 持有
ARMISTICE CAPITAL, LLC 历史持仓 3.09M $68.57M 0.90% 减持
JPMorgan Chase & Co 3.15M $67.15M 0.01% 减持
PERCEPTIVE ADVISORS LLC 历史持仓 2.69M $59.73M 0.95% 减持
Logos Global Management LP 历史持仓 2.55M $56.64M 2.44% 增持
Bank of America Corp 2.23M $49.60M 0.00% 增持
Venrock Adviser, LLC 历史持仓 2.17M $48.28M 1.46% 持有
Goldman Sachs Group 2.16M $47.91M 0.01% 增持
Siren, L.L.C. 历史持仓 2.13M $47.29M 0.96% 减持
Franklin Resources 2.03M $45.10M 0.01% 增持

Q1 2026 — 25 家基金

基金股数金额组合权重变化
T. Rowe Price Investment Management, Inc. 30.79M $558.15M 0.38% 增持
Janus Henderson Group 13.65M $247.43M 0.12% 减持
BlackRock Inc 11.70M $212.12M 0.01% 增持
Atlas Venture Life Science Advisors, LLC 历史持仓 9.13M $165.54M 20.95% 持有
Fidelity Management & Research (FMR) 8.91M $161.52M 0.01% 增持
Orbis Allan Gray Ltd 6.76M $122.60M 0.52% 增持
STATE STREET CORP 6.65M $120.63M 0.00% 减持
VANGUARD CAPITAL MANAGEMENT LLC 6.41M $116.12M 0.00% 新进
PERCEPTIVE ADVISORS LLC 历史持仓 4.67M $84.65M 1.78% 增持
FCPM III SERVICES B.V. 历史持仓 4.64M $84.20M 11.66% 减持
TCG Crossover Management, LLC 历史持仓 4.62M $83.67M 2.39% 持有
VANGUARD PORTFOLIO MANAGEMENT LLC 4.16M $75.46M 0.00% 新进
Vestal Point Capital, LP 历史持仓 4.00M $72.52M 2.03% 增持
Geode Capital Management 3.50M $63.54M 0.00% 增持
ARMISTICE CAPITAL, LLC 历史持仓 3.18M $57.56M 1.14% 减持
Frazier Life Sciences Management, L.P. 历史持仓 3.15M $57.17M 1.47% 持有
JPMorgan Chase & Co 3.25M $55.60M 0.01% 减持
ORBIMED ADVISORS LLC 历史持仓 2.92M $52.90M 1.09% 增持
PRICE T ROWE ASSOCIATES INC /MD/ 2.33M $42.22M 0.01% 持有
Siren, L.L.C. 历史持仓 2.23M $40.41M 1.12% 减持
Venrock Adviser, LLC 历史持仓 2.17M $39.41M 1.47% 持有
Franklin Resources 2.01M $36.42M 0.01% 持有
Deep Track Capital, LP 历史持仓 2.00M $36.26M 0.59% 减持
SAMLYN CAPITAL, LLC 历史持仓 1.92M $34.86M 0.59% 增持
Goldman Sachs Group 1.72M $31.24M 0.01% 减持

Q4 2025 — 25 家基金

基金股数金额组合权重变化
T. Rowe Price Investment Management, Inc. 17.54M $343.08M 0.22% 增持
Janus Henderson Group 13.89M $271.60M 0.12% 减持
Vanguard Group 11.22M $219.38M 0.00% 增持
BlackRock Inc 11.19M $218.89M 0.01% 增持
Atlas Venture Life Science Advisors, LLC 历史持仓 9.13M $178.59M 20.64% 持有
STATE STREET CORP 6.69M $130.91M 0.01% 增持
Fidelity Management & Research (FMR) 6.57M $128.51M 0.01% 增持
FCPM III SERVICES B.V. 历史持仓 5.46M $106.85M 14.01% 持有
ADAGE CAPITAL PARTNERS GP, L.L.C. 5.17M $101.16M 0.15% 增持
Orbis Allan Gray Ltd 4.80M $93.93M 0.39% 新进
TCG Crossover Management, LLC 历史持仓 4.62M $90.27M 2.99% 持有
JPMorgan Chase & Co 3.55M $69.44M 0.01% 增持
Siren, L.L.C. 历史持仓 3.50M $68.52M 2.04% 减持
PERCEPTIVE ADVISORS LLC 历史持仓 3.48M $68.05M 1.28% 增持
Geode Capital Management 3.26M $63.84M 0.00% 增持
ARMISTICE CAPITAL, LLC 历史持仓 3.25M $63.56M 0.80% 增持
Frazier Life Sciences Management, L.P. 历史持仓 3.15M $61.67M 1.66% 增持
Deep Track Capital, LP 历史持仓 2.65M $51.83M 0.92% 增持
Vivo Capital, LLC 历史持仓 2.61M $51.15M 3.31% 持有
PRICE T ROWE ASSOCIATES INC /MD/ 2.32M $45.45M 0.01% 增持
Goldman Sachs Group 2.28M $44.66M 0.02% 增持
Sofinnova Investments, Inc. 历史持仓 2.25M $44.09M 1.90% 增持
ORBIMED ADVISORS LLC 历史持仓 2.20M $43.07M 0.92% 减持
Venrock Adviser, LLC 历史持仓 2.17M $42.52M 2.10% 持有
Franklin Resources 2.01M $39.25M 0.01% 增持

Q3 2025 — 25 家基金

基金股数金额组合权重变化
Janus Henderson Group 14.75M $186.49M 0.09% 增持
Vanguard Group 9.76M $123.47M 0.00% 增持
BlackRock Inc 9.63M $121.88M 0.00% 增持
Atlas Venture Life Science Advisors, LLC 历史持仓 9.13M $115.50M 15.35% 持有
FCPM III SERVICES B.V. 历史持仓 5.46M $69.11M 13.81% 持有
Fidelity Management & Research (FMR) 5.40M $68.33M 0.00% 增持
STATE STREET CORP 5.27M $66.65M 0.00% 增持
Siren, L.L.C. 历史持仓 4.73M $59.82M 2.34% 减持
TCG Crossover Management, LLC 历史持仓 4.62M $58.38M 2.87% 增持
ADAGE CAPITAL PARTNERS GP, L.L.C. 3.55M $44.96M 0.07% 增持
JPMorgan Chase & Co 3.37M $42.57M 0.01% 增持
ARMISTICE CAPITAL, LLC 历史持仓 3.06M $38.76M 0.57% 增持
Marshall Wace 3.01M $38.12M 0.06% 增持
RTW INVESTMENTS, LP 2.89M $36.57M 0.45% 增持
Geode Capital Management 2.87M $36.28M 0.00% 增持
T. Rowe Price Investment Management, Inc. 2.81M $35.58M 0.02% 增持
Vestal Point Capital, LP 历史持仓 2.77M $35.10M 1.58% 增持
BRAIDWELL LP 2.73M $34.54M 1.09% 减持
Frazier Life Sciences Management, L.P. 历史持仓 2.72M $34.38M 1.03% 增持
Saturn V Capital Management LP 历史持仓 2.67M $33.83M 7.42% 增持
Vivo Capital, LLC 历史持仓 2.61M $33.08M 2.66% 增持
Logos Global Management LP 历史持仓 2.40M $30.36M 3.20% 增持
ORBIMED ADVISORS LLC 历史持仓 2.31M $29.27M 0.75% 增持
Venrock Adviser, LLC 历史持仓 2.17M $27.50M 1.55% 持有
Deep Track Capital, LP 历史持仓 2.00M $25.30M 0.71% 新进

Q2 2025 — 25 家基金

基金股数金额组合权重变化
RA CAPITAL MANAGEMENT, L.P. 9.71M $92.48M 1.56% 持有
Janus Henderson Group 9.44M $89.88M 0.04% 减持
Atlas Venture Life Science Advisors, LLC 历史持仓 9.13M $86.92M 13.12% 持有
BlackRock Inc 8.08M $76.91M 0.00% 持有
Vanguard Group 7.65M $72.84M 0.00% 增持
FCPM III SERVICES B.V. 历史持仓 5.46M $52.01M 14.09% 持有
Fidelity Management & Research (FMR) 5.29M $50.39M 0.00% 增持
Siren, L.L.C. 历史持仓 4.84M $46.04M 2.38% 增持
TCG Crossover Management, LLC 历史持仓 3.77M $35.86M 4.10% 增持
STATE STREET CORP 3.36M $31.95M 0.00% 减持
BRAIDWELL LP 3.27M $31.16M 1.23% 减持
ADAGE CAPITAL PARTNERS GP, L.L.C. 3.19M $30.38M 0.05% 新进
JPMorgan Chase & Co 3.09M $29.39M 0.00% 增持
ARMISTICE CAPITAL, LLC 历史持仓 2.56M $24.37M 0.43% 减持
PRICE T ROWE ASSOCIATES INC /MD/ 2.38M $22.70M 0.00% 增持
Geode Capital Management 2.25M $21.46M 0.00% 增持
PERCEPTIVE ADVISORS LLC 历史持仓 2.25M $21.40M 0.80% 减持
Venrock Adviser, LLC 历史持仓 2.17M $20.70M 1.55% 持有
Logos Global Management LP 历史持仓 1.90M $18.09M 2.11% 增持
T. Rowe Price Investment Management, Inc. 1.79M $17.07M 0.01% 增持
RTW INVESTMENTS, LP 1.69M $16.09M 0.23% 持有
Frazier Life Sciences Management, L.P. 历史持仓 1.51M $14.34M 0.57% 增持
Saturn V Capital Management LP 历史持仓 1.46M $13.86M 5.62% 新进
MPM BioImpact LLC 历史持仓 1.45M $13.77M 2.39% 新进
Franklin Resources 1.39M $13.23M 0.00% 减持

查看全部 468 家持有基金 →

新建仓(Q2 2026)

完全清仓(较上季)

基金持仓历史 — 各季度股数(前 20 只基金)

基金Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
BlackRock Inc 14.47M 12.40M 11.70M 11.19M 9.63M 8.08M 8.05M 7.95M 7.79M — — — — — — — — — — —
Fidelity Management & Research (FMR) 11.15M 11.21M 8.91M 6.57M 5.40M 5.29M 5.20M 8.00M 9.03M 5.32M 3.22M 1.28M 846.36K 899.29K 409.06K 574.12K 73.24K 72.83K 72.77K 17.20K
STATE STREET CORP 8.16M — 6.65M 6.69M 5.27M 3.36M 3.61M 3.72M 3.64M 3.20M 4.19M 2.34M 1.94M — — — — — — —
VANGUARD CAPITAL MANAGEMENT LLC 7.55M 6.31M 6.41M — — — — — — — — — — — — — — — — —
VANGUARD PORTFOLIO MANAGEMENT LLC 4.69M 4.05M 4.16M — — — — — — — — — — — — — — — — —
Geode Capital Management 4.40M 3.74M 3.50M 3.26M 2.87M 2.25M 1.96M 1.89M 1.86M 1.77M 1.31M 932.84K 857.71K 739.19K 568.52K 546.55K 533.62K 499.12K 488.80K 482.95K
Atlas Venture Life Science Advisors, LLC 3.44M 6.80M 9.13M 9.13M 9.13M 9.13M 9.13M 8.02M 8.02M 8.02M 8.02M 9.89M 9.89M — — — — — — —
JPMorgan Chase & Co 2.91M 3.15M 3.25M 3.55M 3.37M 3.09M 2.53M 98.39K 101.75K 97.51K 54.37K 41.48K 338.17K 35.61K 2.60K 20.44K 43.78K 35.32K 27.86K 37.84K
Siren, L.L.C. 2.43M 2.13M 2.23M 3.50M 4.73M 4.84M 2.72M 1.35M 1.13M — — — — — — — — — — —
Franklin Resources 1.98M 2.03M 2.01M 2.01M 1.40M 1.39M 1.41M 1.32M 1.34M 1.71M 1.78M 1.91M 1.91M 1.91M 1.89M 1.78M 1.78M 1.75M 1.18M 1.19M
DIMENSIONAL FUND ADVISORS LP 1.98M 1.95M 951.59K 98.07K — — 12.57K 99.58K 166.15K 171.19K 326.63K 805.55K 943.21K — — — — — — —
Fiera Capital Corp 1.44M 789.99K 1.38M — — — — — — — — — — — — — — — — —
Aberdeen Group plc 1.35M 1.54M 1.43M 1.11M 556.73K 483.96K 314.59K 25.80K — 17.87K — — — — — — — — — —
VANGUARD FIDUCIARY TRUST CO 1.24M 988.95K 947.44K — — — — — — — — — — — — — — — — —
Morgan Stanley 1.17M 746.20K 929.00K 1.21M 1.42M 1.36M 1.39M 753.59K 1.05M 559.05K 962.16K 2.02M 107.74K 114.84K 113.63K 64.43K 129.54K 228.05K 304.54K 373.92K
BNY Mellon 776.30K 409.80K 401.62K 353.50K 317.36K 269.66K 232.63K 234.80K 234.10K 311.50K 204.27K 170.56K 157.44K 150.25K 126.86K 127.30K 119.57K 109.50K 112.09K 115.95K
Marshall Wace 686.68K 1.49M 83.15K 676.98K 3.01M 447.81K — 24.50K — 273.57K 53.70K — 22.05K 22.05K 132.34K 22.05K 64.91K 349.28K 349.28K 349.28K
TD ASSET MANAGEMENT INC 612.38K 548.11K 529.31K 419.76K 20.38K — 21.66K 72.03K 108.83K 152.21K 74.80K — 23.00K — — — — — — —
RAYMOND JAMES FINANCIAL INC 544.19K 576.35K 451.64K 530.34K 76.91K 51.48K 53.09K 99.33K — — — — — — — — — — — —
Vivo Capital, LLC 514.40K 1.56M 1.56M 2.61M 2.61M 1.11M 1.11M 1.11M 1.11M 1.64M 1.64M 1.04M 1.04M — — — — — — —

下载持有人名单 (CSV)

常见问题

Which funds hold DYN?

As of 2026-Q2, 256 institutional funds reported holding DYN (DYNE THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $4.19B.

How many shares of DYN do institutions own?

13F filers reported 192.73M shares of DYN, worth $4.19B in aggregate at the end of 2026-Q2.

Is institutional ownership of DYN rising or falling?

Share counts moved +2.1% versus the prior quarter — accumulation.

Who are the top institutional holders of DYN?

The largest 13F holders are T. Rowe Price Investment Management, Inc., Jupiter Topco LLC, Janus Henderson Group, BlackRock Inc, Vanguard Group; the top 25 are ranked at the top of this page.

Who are the major shareholders of DYNE THERAPEUTICS INC?

The major shareholders of DYNE THERAPEUTICS INC (DYN) by reported 13F value are T. Rowe Price Investment Management, Inc., Jupiter Topco LLC, Janus Henderson Group, BlackRock Inc, Vanguard Group, among 468 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

将本股票嵌入你的网站

复制下面的代码,即可在你的博客或论坛上展示「哪些传奇投资人持有 DYN」的实时名单——免费、自动更新、回链 HoldingsHub。

<iframe src="https://holdingshub.top/stocks/DYN/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

预览可嵌入组件 →